Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.4K citations · Full text

Life Sciences, Immunology, Immunopathology +9

CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

Harold Glucksberg, Rainer Storb, A Fefer et al. · Transplantation · 1974 · 3.7K citations

Medicine, Hematology, Immunology +14

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Leo Luznik, Paul V. O’Donnell, Heather J. Symons et al. · Biology of Blood and Marrow Transplantation · 2008 · 1.9K citations · Full text

Medicine, Hematology, Oncology +16

Defining the Intensity of Conditioning Regimens: Working Definitions

Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo et al. · Biology of Blood and Marrow Transplantation · 2009 · 1.8K citations · Full text

Medicine, Hematology, Cell Therapy +9

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17